Kibbutz Glil Yam
Central District
Tel Aviv 4690500
Israel
https://imcannabis.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 95
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Marc Lustig M.B.A., M.Sc. | Executive Chairman | 94.67k | N/A | 1974 |
Mr. Oren Shuster | CEO & Director | 347.03k | N/A | N/A |
Mr. Uri Birenberg | Chief Financial Officer | 237.33k | N/A | 1976 |
Mr. Richard Balla | Chief Executive Officer of Adjupharm | 214.2k | N/A | N/A |
Advocate Michal Lebovitz Nissimov | General Counsel | N/A | N/A | N/A |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.